Q4 2020

Filed Apr 14, 2021 · 10-K · 104 days after period end · 0001213900-21-021486

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$218.93K

derivedno prior Q4 2019 on file

Net Income

-$89.54K

derivedno prior Q4 2019 on file

EPS, diluted—

Same quarter

no prior Q4 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2020 · filed Apr 14, 2021 · 104 d after period end

Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR